Homocysteine-lowering treatment with folic acid, cobalamin, and pyridoxine does not reduce blood markers of inflammation, endothelial dysfunction, or hypercoagulability in patients with previous transient ischemic attack or stroke: a randomized substudy of the VITATOPS trial.

Details

Language :

English

ISSN :

00392499

Volume :

36

Issue :

1

Database :

Complementary Index

Journal :

Stroke (00392499)

Publication Type :

Academic Journal

Accession number :

106494717

Full Text :

https://doi.org/10.1161/01.str.0000150494.91762.70